Topic: NOVAVAX
61 results were found.
Novavax Q4 loss $178 million - February 29, 2024
Novavax's updated COVID-19 vaccine now option for all 194 WHO member states - November 28, 2023
Novavax Q3 loss decreases - November 10, 2023
Novavax's updated COVID-19 vaccine approved in EU - November 1, 2023
Novavax's updated XBB COVID vaccine induced neutralizing responses against emerging subvariants - August 22, 2023
Novavax Q2 revenue $424 million - August 9, 2023
Novavax's Nuvaxovid receives full marketing authorization in EU for COVID prevention - July 7, 2023
Novavax's Nuvaxovid receives positive CHMP opinion for full MA for prevention of COVID in EU - May 27, 2023
Novavax says it may not survive - March 2, 2023
Novavax Q4 revenue $357 million - March 1, 2023
Novavax initiates Phase 2 trial for COVID-19-influenza combination and stand-alone influenza vaccine candidates - December 31, 2022
WHO updates emergency use listing for Novavax Nuvaxovid COVID-19 vaccine - November 30, 2022
Novavax ends COVID vaccine sale agreement with Gavi - November 23, 2022
Novavax appoints Rick Rodgers to board of directors - November 2, 2022
Novavax announces positive results from Phase 1/2 clinical trial of its CIC vaccine candidate - October 14, 2022
Novavax to share new data from growing vaccine portfolio at WVC Europe 2022 - October 11, 2022
Novavax COVID-19 vaccine granted expanded conditional marketing authorization in EU for booster for 18 and older - September 13, 2022
Swissmedic authorizes Novavax Nuvaxovid COVID-19 vaccine for adolescents 12-17 and as booster in adults 18 and older - September 3, 2022
EU regulator backs use of Novavax COVID shot as booster for adults aged 18 and older - September 2, 2022
Novavax COVID-19 vaccine approved for adolescents in UK - August 27, 2022
New Zealand grants provisional approval for Novavax COVID-19 booster - August 18, 2022
FDA authorizes Novavax COVID-19 vaccine for emergency use in adults - July 14, 2022
U.S. secures 3.2 million doses of Novavax COVID-19 vaccine - July 12, 2022
Novavax seeks UK nod for COVID-19 vaccine use in adolescents - May 5, 2022
Japan expert panel OKs use of Novavax COVID-19 vaccine - April 19, 2022
Novavax asks EU to approve coronavirus vaccine for adolescents - April 1, 2022
New Zealand approves third COVID-19 vaccine Novavax - March 1, 2022
Novavax announces shipments of its COVID-19 vaccine to European Union member states - February 24, 2022
Novavax COVID-19 vaccine becomes fifth vaccine approved for use in UK - February 3, 2022
Germany to receive 3.8 million doses of Novavax's new COVID vaccine in Q1 - January 25, 2022
South Korea authorises Novavax COVID-19 vaccine, imports Pfizer pills - January 12, 2022
Novavax says it could start making Omicron specific vaccine in January - December 3, 2021
Novavax developing vaccine that targets new COVID-19 Omicron variant - November 27, 2021
EMA receives application for conditional marketing authorisation of Novavax’s COVID-19 vaccine Nuvaxovid - November 18, 2021
Novavax files COVID-19 vaccine for emergency use listing with WHO - November 5, 2021
Novavax Q3 net loss $322.4 million but revenue $178.8 million - November 5, 2021
Indonesia becomes first country to approve Novavax COVID-19 vaccine - November 3, 2021
Novavax seeks WHO approval for COVID-19 vaccine - September 24, 2021
Japan to get 150m doses of Novavax's COVID-19 vaccine candidate - September 9, 2021
EU announces pre-sale agreement with Novavax for COVID-19 vaccine - August 5, 2021
Novavax Q1 net loss $223 million - May 11, 2021
Gavi signs agreement with Novavax to secure doses on behalf of COVAX - May 10, 2021
Novavax starts allowing participants on placebo to get COVID-19 vaccine in trials - April 6, 2021
GSK to support manufacture of Novavax COVID-19 vaccine - April 3, 2021
Novavax Q4 loss $177.6 million - March 2, 2021
Novavax vaccine over 89% effective in stage 3 trials - January 29, 2021
Novavax plans major expansion in Montgomery County, Maryland, at least 400 new jobs - November 6, 2020
10,000 volunteers: Novavax coronavirus vaccine enters late stage trials in UK - September 25, 2020
Novavax received $1.6 billion grant for potential coronavirus vaccine - July 7, 2020
Novavax appoints Bob Darius as SVP, quality - March 21, 2016
Novavax appoints Jeffrey Stoddard VP, medical affairs - January 11, 2016
Novavax appoints Gail K. Boudreaux to board - June 19, 2015
Novavax appoints VP, government affairs - March 12, 2015
Novavax appoints SVP, CFO - June 25, 2013
Novavax adds Richard H. Douglas to the board of directors - August 6, 2010
Novavax: Gregory Glenn new chief scientific officer - July 6, 2010
Novavax: Mark Thornton new senior vice president - May 24, 2010
Novavax elects James F. Young to the board - April 7, 2010
Novavax: Stanley Erck elected as executive chairman - February 16, 2010
Novavax appoints Frederick W. Driscoll as VP, CFO and treasurer - August 7, 2009
Novavax appoints Stanley Erck to board of directors - June 26, 2009